Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zhu X et al. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. 2000 J. Immunol. Methods pmid:10854610
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Panayiotou A et al. Lipid fractions with aggregatory and antiaggregatory activity toward platelets in fresh and fried cod (Gadus morhua): correlation with platelet-activating factor and atherogenesis. 2000 J. Agric. Food Chem. pmid:11312810
Kimura I et al. Release of endothelins and platelet-activating factor by a rat pleural mesothelial cell line. 2000 Eur. Respir. J. pmid:10678641
Orozco AS et al. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. 2000 Infect. Immun. pmid:10678917
Ishihara Y et al. Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. 2000 Infect. Immun. pmid:10678975
Fujimura M et al. No involvement of lipid mediators in a guinea pig model of ultrasonically nebulized distilled water-induced bronchoconstriction. 2000 Prostaglandins Other Lipid Mediat. pmid:10680775
Sugano T et al. Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts. 2000 Biol. Reprod. pmid:10684793
Fukuda Y et al. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models. 2000 Eur. J. Pharmacol. pmid:10708725
Neuberger Y et al. A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum. 2000 FEBS Lett. pmid:10708753
Nikbakht-Sangari M et al. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. 2000 Immunol. Invest. pmid:10709843
Turner PJ et al. Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10711351
Maruoka S et al. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. 2000 Am. J. Respir. Crit. Care Med. pmid:10712344
McClenahan DJ et al. Role of platelet-activating factor in alveolar septal injury associated with experimentally induced pneumonic pasteurellosis in calves. 2000 Am. J. Vet. Res. pmid:10714514
Yamakawa Y et al. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. 2000 Ann. Surg. pmid:10714632
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Baker RR and Chang HY The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: the control of nuclear lyso platelet-activating factor metabolism. 2000 Mol. Cell. Biochem. pmid:11204449
Mannori G et al. Interaction of tumor cells with vascular endothelia: role of platelet-activating factor. 2000 Clin. Exp. Metastasis pmid:11206844
Herrero-Fresneda I et al. Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. 2000 Transplantation pmid:11190497
Yildirim G et al. Effects of platelet-activating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. 2000 Undersea Hyperb Med pmid:11191161
Grimminger F et al. PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10666110
Franke B et al. Sequential regulation of the small GTPase Rap1 in human platelets. 2000 Mol. Cell. Biol. pmid:10629034
Haines DD et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. 2000 J. Cardiovasc. Pharmacol. pmid:10630731
Fukuda S et al. Mechanisms for regulation of fluid shear stress response in circulating leukocytes. 2000 Circ. Res. pmid:10625314
Kim DD et al. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch. 2000 Microvasc. Res. pmid:10625566
Montrucchio G et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10634803
Keularts IM et al. alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. 2000 J. Biol. Chem. pmid:10636873
Tong N et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. 2000 J. Immunol. pmid:10640747
Clavijo LC et al. Platelet-activating factor and bacteremia-induced pulmonary hypertension. 2000 J. Surg. Res. pmid:10644485
Owaki T et al. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10644608
Ibe BO et al. Platelet activating factor acetylhydrolase activity in lamb lungs is up-regulated in the immediate newborn period. 2000 Mol. Genet. Metab. pmid:10655157
Martin-Chouly CA et al. Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. 2000 Prostaglandins Other Lipid Mediat. pmid:10751643
Adams JM et al. G-protein receptor responses in trauma neutrophils. 2000 J Trauma pmid:11130495
Asimakopoulos G et al. Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin. 2000 Perfusion pmid:11131212
Luu NT et al. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils. 2000 J. Immunol. pmid:10820279
Sugatani J et al. Inhibition of rabbit platelet aggregation by nucleoside 5'-alkylphosphates: correlation with inhibition of agonist-induced calcium influx. 2000 Biochem. Pharmacol. pmid:10825464
Ohishi S [Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction]. 2000 Yakugaku Zasshi pmid:10825809
Asai Y et al. Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). 2000 Drug Dev Ind Pharm pmid:10826115
Desplat V et al. Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. 2000 Cancer Lett. pmid:10737702
Boccellino M et al. Effect of platelet-activating factor receptor expression on CHO cell motility. 2000 J. Cell. Physiol. pmid:10737901
Hagi A et al. Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor. 2000 J. Med. Invest. pmid:10740976
Tan XD et al. Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. 2000 Br. J. Pharmacol. pmid:10742310
Wiese A et al. Structure-dependent effects of glucose-containing analogs of platelet activating factor (PAF) on membrane integrity. 2000 Biol. Chem. pmid:10746745
Howard KM and Olson MS The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. 2000 J. Biol. Chem. pmid:10748027
Yamada Y et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. 2000 Atherosclerosis pmid:10781653
Logan JE and Roudebush WE Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos. 2000 Early Pregnancy pmid:11719820
Lendvai N et al. Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. 2000 J. Immunol. pmid:10754337
Gu M et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. 2000 Transplantation pmid:11045637
Poeze M et al. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. 2000 Shock pmid:11049104
Karlstad MD et al. Platelet-activating factor (PAF)-induced decreases in whole-body and skeletal muscle protein synthesis. 2000 Shock pmid:11049115
James JH and Fischer JE Are the effects of platelet-activating factor on muscle metabolism of carbohydrates, amino acids and proteins attributable mainly to epinephrine? 2000 Shock pmid:11049116
Dichmann S et al. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells. 2000 J. Cell. Physiol. pmid:11056009
Grassi S and Pettorossi VE Role of nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2000 Neuroscience pmid:11068144
Bussolati B et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. 2000 Am. J. Pathol. pmid:11073830
Yoshimatsu Y et al. Platelet-activating factor-induced intracellular calcium waves in human uterine myometrial cells. 2000 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:11074135
Walther A et al. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia. 2000 J. Surg. Res. pmid:11027469
Ciesla DJ et al. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. 2000 Shock pmid:11028541
De Geest B et al. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:11031226
McLarnon JG et al. Anion channels modulate store-operated calcium influx in human microglia. 2000 Cell Calcium pmid:11032781
Lonardoni MV et al. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. 2000 Infect. Immun. pmid:11035745
Mul FP et al. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. 2000 J. Leukoc. Biol. pmid:11037975
Peri A et al. Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. 2000 Int. J. Cancer pmid:11058867
Tiano L et al. Oxidative response and membrane modification of diabetic platelets challenged with PAF. 2000 Prostaglandins Other Lipid Mediat. pmid:11060899
Bracco E et al. Cell-cell signaling and adhesion in phagocytosis and early development of Dictyostelium. 2000 Int. J. Dev. Biol. pmid:11061438
Biancone L et al. Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. 2000 Transplantation pmid:11063341
Okunuki H et al. Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice. 2000 Immunol. Lett. pmid:11064108
Toró A et al. Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. 2000 Org. Lett. pmid:10964353
Durán WN et al. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. 2000 Microvasc. Res. pmid:10964584
Wereszczynska-Siemiatkowska U et al. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. 2000 Exp. Toxicol. Pathol. pmid:10965985
Prescott SM et al. Platelet-activating factor and related lipid mediators. 2000 Annu. Rev. Biochem. pmid:10966465
Kim JD et al. Platelet activating factor acetylhydrolase decreases lung reperfusion injury. 2000 Ann. Thorac. Surg. pmid:10969656
Suzuki T et al. Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon. 2000 Eur. J. Pharmacol. pmid:10988347
Kallan NC and Halcomb RL Synthesis of the ring system of phomactin D using a Suzuki macrocyclization. 2000 Org. Lett. pmid:10990428
Turner PJ et al. Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10991932
Pávó I et al. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. 2000 Eur. J. Pharmacol. pmid:10940373
Balestrieri ML and Lee T Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothlial cells. 2000 FEBS Lett. pmid:10940389
Gálvez J et al. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. 2000 Br. J. Pharmacol. pmid:10952687
Maniscalco M et al. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. 2000 Allergy pmid:10955702
Oktar BK et al. Endothelin-1-induced PMN infiltration and mucosal dysfunction in the rat small intestine. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10960346
Jeon SY et al. Ultrastructural changes in platelet activating factor-induced epithelial damage in rabbit maxillary sinus mucosa. 2000 Ann. Otol. Rhinol. Laryngol. pmid:10961804
Saito S et al. Modulatory roles of RANTES in IL-4 production by human blood CD4(+)T cells. 2000 Cytokine pmid:10975998
Tanaka R et al. Genetics of immunoglobulin A nephropathy. 2000 Ann. Acad. Med. Singap. pmid:10976391
Denizot Y et al. Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy. 2000 Nephrol. Dial. Transplant. pmid:10978389
Clark WF et al. A novel treatment for lupus nephritis: lignan precursor derived from flax. 2000 Lupus pmid:10981647
Klabunde RE and Anderson DE Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage. 2000 Eur. J. Pharmacol. pmid:10996604
Nieswandt B et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. 2000 Blood pmid:11001906
Guan Z et al. [Role of interleukin-6 and platelet-activating factor in delaying neutrophil apoptosis]. 2000 Wei Sheng Yan Jiu pmid:12725051
Burgermeister E et al. Inhibition of cytosolic phospholipase A(2) attenuates activation of mitogen-activated protein kinases in human monocytic cells. 2000 Eur. J. Pharmacol. pmid:10675727
Suzuki S et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. 2000 Transplantation pmid:10868624
Serradji N et al. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication. 2000 J. Med. Chem. pmid:10841793
Ma X and Bazan HE Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10845588
Kobayashi N et al. Transepithelial migration of activated eosinophils induces a decrease of E-cadherin expression in cultured human nasal epithelial cells. 2000 Clin. Exp. Allergy pmid:10848899
Choi JH et al. Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. 2000 Inflammation pmid:10921504
Smalley DM et al. The local effect of PAF on leukocyte adherence to small bowel mesenteric venules following intra-abdominal contamination. 2000 Inflammation pmid:10921505
O'Brien JG et al. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. 2000 Inflammation pmid:10921506
Klyubin IV et al. The role of reactive oxygen species in membrane potential changes in macrophages and astrocytes. 2000 Membr Cell Biol pmid:10926373
Roudebush WE and Purnell ET Platelet-activating factor content in human spermatozoa and pregnancy outcome. 2000 Fertil. Steril. pmid:10927041
Matsunaga Y et al. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction. 2000 Br. J. Pharmacol. pmid:10928955
Capasso R et al. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. 2000 Fitoterapia pmid:10930724
Xu H et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. 2000 Am. J. Kidney Dis. pmid:10873870